CompletedPhase 2NCT02862210

Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia

Studying Frontotemporal dementia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Columbia University
Principal Investigator
Edward Huey, MD, M.D
Brown University
Intervention
Lithium Carbonate(drug)
Enrollment
17 enrolled
Eligibility
40-85 years · All sexes
Timeline
20172022

Study locations (1)

Collaborators

Alzheimer's Drug Discovery Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02862210 on ClinicalTrials.gov

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

See all trials for Frontotemporal dementia

← Back to all trials